Literature DB >> 18785635

Clinical correlates of depressive symptoms in familial Parkinson's disease.

Nathan Pankratz1, Karen S Marder, Cheryl A Halter, Alice Rudolph, Cliff W Shults, William C Nichols, Tatiana Foroud.   

Abstract

Depression is one of the most common nonmotor complications of Parkinson's disease (PD) and has a major impact on quality of life. Although several clinical factors have been associated with depression in PD, the relationship between depression and stage of illness as well as between depression and degree of disability remains controversial. We have collected clinical data on 1,378 PD cases from 632 families, using the Unified Parkinson's Disease Rating Scale (UPDRS) Parts II (activities of daily living) & III (motor), the Mini-Mental State Exam, the Geriatric Depression Scale (GDS), and the Blessed Functional Activity Scale (Blessed). Analyses were performed using the 840 individuals with verified PD and without evidence of cognitive decline. Logistic regression was used to identify study variables that individually and collectively best predicted the presence of depressive symptoms (GDS >or= 10). After correcting for multiple tests, depressive symptoms were significantly associated with Hoehn and Yahr stage and other clinical measures but not with any genetic variant (parkin, LRRK2, APOE). The Blessed score, education, presence of a first degree relative with signs of depression, and UPDRS Part II were found to best predict depressive symptomatology (R(2) = 0.33; P = 4 x 10(-48)). Contrary to several reports, the results from this large study indicate that stage of illness, motor impairment, and functional disability are strongly correlated with depressive symptoms.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18785635      PMCID: PMC2872794          DOI: 10.1002/mds.22285

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  39 in total

1.  An essay on the shaking palsy. 1817.

Authors:  James Parkinson
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2002       Impact factor: 2.198

2.  Linkage stratification and mutation analysis at the Parkin locus identifies mutation positive Parkinson's disease families.

Authors:  W C Nichols; N Pankratz; S K Uniacke; M W Pauciulo; C Halter; A Rudolph; P M Conneally; T Foroud
Journal:  J Med Genet       Date:  2002-07       Impact factor: 6.318

3.  Risk factors for dementia, depression and psychosis in long-standing Parkinson's disease.

Authors:  N Giladi; T A Treves; D Paleacu; H Shabtai; Y Orlov; B Kandinov; E S Simon; A D Korczyn
Journal:  J Neural Transm (Vienna)       Date:  2000       Impact factor: 3.575

4.  Heterozygosity for a mutation in the parkin gene leads to later onset Parkinson disease.

Authors:  T Foroud; S K Uniacke; L Liu; N Pankratz; A Rudolph; C Halter; C Shults; K Marder; P M Conneally; W C Nichols
Journal:  Neurology       Date:  2003-03-11       Impact factor: 9.910

5.  The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects.

Authors:  G Blessed; B E Tomlinson; M Roth
Journal:  Br J Psychiatry       Date:  1968-07       Impact factor: 9.319

6.  Functional decline in Parkinson disease.

Authors:  J Jankovic; A S Kapadia
Journal:  Arch Neurol       Date:  2001-10

7.  Depression in Parkinson's disease: clinical correlates and outcome.

Authors:  A Rojo; M Aguilar; M T Garolera; E Cubo; I Navas; S Quintana
Journal:  Parkinsonism Relat Disord       Date:  2003-10       Impact factor: 4.891

Review 8.  Depression in Parkinson's disease: conceptual issues and clinical challenges.

Authors:  Albert F G Leentjens
Journal:  J Geriatr Psychiatry Neurol       Date:  2004-09       Impact factor: 2.680

9.  LRRK2 mutation analysis in Parkinson disease families with evidence of linkage to PARK8.

Authors:  W C Nichols; V E Elsaesser; N Pankratz; M W Pauciulo; D K Marek; C A Halter; A Rudolph; C W Shults; T Foroud
Journal:  Neurology       Date:  2007-09-05       Impact factor: 9.910

10.  Genome screen to identify susceptibility genes for Parkinson disease in a sample without parkin mutations.

Authors:  Nathan Pankratz; William C Nichols; Sean K Uniacke; Cheryl Halter; Alice Rudolph; Cliff Shults; P Michael Conneally; Tatiana Foroud
Journal:  Am J Hum Genet       Date:  2002-06-07       Impact factor: 11.025

View more
  10 in total

1.  Mood and cognition in leucine-rich repeat kinase 2 G2019S Parkinson's disease.

Authors:  Vicki Shanker; Mark Groves; Gary Heiman; Christina Palmese; Rachel Saunders-Pullman; Laurie Ozelius; Deborah Raymond; Susan Bressman
Journal:  Mov Disord       Date:  2011-05-24       Impact factor: 10.338

2.  The relation between depression and parkin genotype: the CORE-PD study.

Authors:  A Srivastava; M-X Tang; H Mejia-Santana; L Rosado; E D Louis; E Caccappolo; C Comella; A Colcher; A Siderowf; D Jennings; M Nance; S Bressman; W K Scott; C Tanner; S Mickel; H Andrews; C Waters; S Fahn; L Cote; S Frucht; B Ford; R N Alcalay; B Ross; M Orbe Reilly; M Rezak; K Novak; J H Friedman; R D Pfeiffer; L Marsh; B Hiner; D Merle; R Ottman; L N Clark; K Marder
Journal:  Parkinsonism Relat Disord       Date:  2011-12       Impact factor: 4.891

Review 3.  Depression in Patients with Parkinson's Disease: Current Understanding of its Neurobiology and Implications for Treatment.

Authors:  Stéphane Prange; Hélène Klinger; Chloé Laurencin; Teodor Danaila; Stéphane Thobois
Journal:  Drugs Aging       Date:  2022-06-16       Impact factor: 4.271

4.  Parkin dosage mutations have greater pathogenicity in familial PD than simple sequence mutations.

Authors:  N Pankratz; D K Kissell; M W Pauciulo; C A Halter; A Rudolph; R F Pfeiffer; K S Marder; T Foroud; W C Nichols
Journal:  Neurology       Date:  2009-07-28       Impact factor: 9.910

5.  Alpha-synuclein and familial Parkinson's disease.

Authors:  Nathan Pankratz; William C Nichols; Veronika E Elsaesser; Michael W Pauciulo; Diane K Marek; Cheryl A Halter; Joanne Wojcieszek; Alice Rudolph; Ronald F Pfeiffer; Tatiana Foroud
Journal:  Mov Disord       Date:  2009-06-15       Impact factor: 10.338

6.  The role of cognitive-behavioural therapy for patients with depression in Parkinson's disease.

Authors:  Andreas Charidimou; John Seamons; Caroline Selai; Anette Schrag
Journal:  Parkinsons Dis       Date:  2011-06-08

7.  Altered Resting-State Brain Activity and Connectivity in Depressed Parkinson's Disease.

Authors:  Xiao Hu; Xiaopeng Song; Erfeng Li; Jiajia Liu; Yonggui Yuan; Weiguo Liu; Yijun Liu
Journal:  PLoS One       Date:  2015-07-06       Impact factor: 3.240

8.  Major depressive disorder in Parkinson's disease: a cross-sectional study from Sri Lanka.

Authors:  Tharini Ketharanathan; Raveen Hanwella; Rajiv Weerasundera; Varuni A de Silva
Journal:  BMC Psychiatry       Date:  2014-09-30       Impact factor: 3.630

9.  Depressive symptoms before and after Parkinson's diagnosis-A longitudinal analysis.

Authors:  Shengfang Song; Zhehui Luo; Chenxi Li; Xuemei Huang; Eric J Shiroma; Eleanor M Simonsick; Honglei Chen
Journal:  PLoS One       Date:  2022-07-29       Impact factor: 3.752

10.  Clinical Heterogeneity Among LRRK2 Variants in Parkinson's Disease: A Meta-Analysis.

Authors:  Li Shu; Yuan Zhang; Hongxu Pan; Qian Xu; Jifeng Guo; Beisha Tang; Qiying Sun
Journal:  Front Aging Neurosci       Date:  2018-09-19       Impact factor: 5.750

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.